TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataKd: 3.20nMAssay Description:Binding constant for PIK3C2G kinase domainMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 4nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 20nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 29.3nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 30nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 39nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataKd: 40nMAssay Description:Binding affinity to human PIK3C2GMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataKd: 41nMAssay Description:Binding constant for PIK3C2G kinase domainMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 41nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 49nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 50.7nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 63nMAssay Description:Inhibition of PIK3C2G (unknown origin) assessed as reduction in substrate phosphorylation by FRET Adapta assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 75.9nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 96nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 100nMAssay Description:The commercially available kits or systems can be used to screen for inhibitors and/or agonists of PI3-Ks including but not limited to PI3-Kinase α, ...More data for this Ligand-Target Pair
